[EFFECT] BridgeBio Oncology Therapeutics, Inc. SEC Filing Filing Impact (Neutral) Filing Sentiment (Neutral) Form Type EFFECT 05/05/2026 - 12:15 AM ⛶ Fullscreen UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: May 4, 2026 Accession Number: 0001193125-26-197901 Submission Type: POS AM CIK: 0001869105 Company Name: BridgeBio Oncology Therapeutics, Inc. File Number: 333-289940 Source: View Original Filing on SEC EDGAR
